Cstone Pharma-B (02616) announced interim results: 截至二零二六年六月三十日止六個月中期業績公告, net profit attributable to owners RMB-2.5bn Title: 截至二零二六年六月三十日止六個月中期業績公告 Revenue: RMB2.1bn Net profit: RMB-2.5bn Profit attributable to owners: RMB-2.5bn
